Insider Buy/Sell Ratio — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Technology
Buys453
Sells8756
Buy $$194.51M
Sell $$11.97B
Ratio1:61.54
% Change vs. Prior
Ratio -98.3%Value -58.9%
Consumer Cyclical
Buys398
Sells1789
Buy $$999.71M
Sell $$5.91B
Ratio1:5.91
% Change vs. Prior
Ratio -30.6%Value +21.8%
Healthcare
Buys651
Sells4538
Buy $$384.87M
Sell $$6.41B
Ratio1:16.65
% Change vs. Prior
Ratio +70.9%Value -46.4%
Energy
Buys229
Sells558
Buy $$308.30M
Sell $$5.86B
Ratio1:19.01
% Change vs. Prior
Ratio +187.9%Value +31.6%
Financial Services
Buys1050
Sells2755
Buy $$580.97M
Sell $$3.90B
Ratio1:6.71
% Change vs. Prior
Ratio -48.5%Value -5.3%
Industrials
Buys503
Sells2025
Buy $$1.48B
Sell $$2.47B
Ratio1:1.67
% Change vs. Prior
Ratio +597.6%Value -12.7%
Consumer Defensive
Buys221
Sells566
Buy $$66.82M
Sell $$1.49B
Ratio1:22.35
% Change vs. Prior
Ratio -38.8%Value -30.2%
Communication Services
Buys170
Sells900
Buy $$155.21M
Sell $$998.57M
Ratio1:6.43
% Change vs. Prior
Ratio +22.7%Value -22.4%
Real Estate
Buys260
Sells214
Buy $$52.51M
Sell $$330.77M
Ratio1:6.30
% Change vs. Prior
Ratio +16.2%Value +25.1%
Basic Materials
Buys183
Sells219
Buy $$45.30M
Sell $$307.11M
Ratio1:6.78
% Change vs. Prior
Ratio +92.8%Value -50.4%
Utilities
Buys106
Sells176
Buy $$75.32M
Sell $$108.11M
Ratio1:1.44
% Change vs. Prior
Ratio +671.5%Value -79.7%
By Industry
Oil & Gas Exploration & Production
Buys119
Sells124
Buy $$158.42M
Sell $$4.16B
Ratio1:26.23
% Change vs. Prior
Ratio +115.5%Value +65.8%
Software - Infrastructure
Buys79
Sells2663
Buy $$17.85M
Sell $$2.65B
Ratio1:148.64
% Change vs. Prior
Ratio -21.3%Value -32.7%
Computer Hardware
Buys2
Sells1964
Buy $$9.90K
Sell $$2.63B
Ratio1:265408.49
% Change vs. Prior
Ratio -80.5%Value +17.3%
Software - Application
Buys183
Sells2006
Buy $$138.79M
Sell $$2.40B
Ratio1:17.32
% Change vs. Prior
Ratio -52.6%Value -14.4%
Biotechnology
Buys414
Sells2629
Buy $$325.21M
Sell $$1.87B
Ratio1:5.75
% Change vs. Prior
Ratio +68.0%Value -43.2%
Semiconductors
Buys110
Sells962
Buy $$11.64M
Sell $$2.09B
Ratio1:179.64
% Change vs. Prior
Ratio +418.4%Value -35.6%
Banks - Regional
Buys354
Sells1061
Buy $$92.40M
Sell $$1.46B
Ratio1:15.83
Specialty Retail
Buys71
Sells818
Buy $$139.77M
Sell $$1.38B
Ratio1:9.90
% Change vs. Prior
Ratio +601.3%Value -8.0%
Waste Management
Buys88
Sells15
Buy $$1.39B
Sell $$4.42M
Ratio314.13:1
Medical - Care Facilities
Buys4
Sells85
Buy $$346.12K
Sell $$1.25B
Ratio1:3610.34
Medical - Instruments & Supplies
Buys16
Sells151
Buy $$2.35M
Sell $$1.21B
Ratio1:514.30
% Change vs. Prior
Ratio -56.2%Value -67.2%
Information Technology Services
Buys37
Sells175
Buy $$18.11M
Sell $$1.19B
Ratio1:65.89
% Change vs. Prior
Ratio +117.3%Value -14.3%
Medical - Diagnostics & Research
Buys16
Sells746
Buy $$3.20M
Sell $$1.14B
Ratio1:354.38
% Change vs. Prior
Ratio -53.5%Value -4.6%
Leisure
Buys5
Sells94
Buy $$1.37M
Sell $$1.12B
Ratio1:820.01
% Change vs. Prior
Ratio -79.3%Value -13.8%
Asset Management
Buys325
Sells243
Buy $$354.97M
Sell $$761.85M
Ratio1:2.15
% Change vs. Prior
Ratio +237.6%Value -1.6%
Transactions (27626)
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,617
Price
$516.93
Total Value
$835.87K
Shares Held After
47,940
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,360
Price
$515.93
Total Value
$701.67K
Shares Held After
49,557
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,795
Price
$514.82
Total Value
$924.11K
Shares Held After
50,917
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
760
Price
$512.92
Total Value
$389.82K
Shares Held After
52,712
% of Holdings
1.4%
NETFLIX INC (NFLX)
Peters Gregory K — Director
Shares
27,312
Price
$73.54
Total Value
$2.01M
Shares Held After
120,931
% of Holdings
18.4%
Velocity Financial, Inc. (VEL)
Szczepaniak Mark R — Chief Financial Officer
Shares
400
Price
$18.00
Total Value
$7.20K
Shares Held After
66,400
% of Holdings
0.6%
Burke&Herbert Financial Services Corp. (BHRB)
McLaughlin Shawn Patrick — Director
Shares
1,000
Price
$73.25
Total Value
$73.25K
Shares Held After
71,000
% of Holdings
1.4%
Rhinebeck Bancorp, Inc. (RBKB)
Vitale Michael — EVP, Head of Comm Banking
Shares
4,834
Price
$12.35
Total Value
$59.70K
Shares Held After
22,414
% of Holdings
21.6%
WILSON BANK HOLDING CO (WBHC)
CLEMONS JAMES RANDALL — Director
Shares
2,982
Price
$83.45
Total Value
$248.85K
Shares Held After
116,090
% of Holdings
2.6%
FARMERS NATIONAL BANC CORP /OH/ (FMNB)
Wenick Mark J — SEVP/Chief Wealth Mgt Officer
Shares
5,000
Price
$15.97
Total Value
$79.85K
Shares Held After
32,020
% of Holdings
13.5%
SILICOM LTD. (SILC)
Gilad Eran — CFO
Shares
6,975
Price
$44.44
Total Value
$309.97K
Shares Held After
0
% of Holdings
100.0%
SILICOM LTD. (SILC)
Gilad Eran — CFO
Shares
25
Price
$46.56
Total Value
$1.16K
Shares Held After
6,975
% of Holdings
0.4%
Thornburg Income Builder Opportunities Trust (TBLD)
Kritzmire Anne W. — TRUSTEE
Shares
3,440
Price
$22.20
Total Value
$76.37K
Shares Held After
4,840
% of Holdings
71.1%
Infleqtion, Inc. (INFQ)
MAVERICK CAPITAL LTD — Director
Shares
1,324
Price
$10.88
Total Value
$14.41K
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
76,418
Price
$21.04
Total Value
$1.61M
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
6,763
Price
$21.61
Total Value
$146.15K
Shares Held After
55,611
% of Holdings
10.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
100
Price
$21.99
Total Value
$2.20K
Shares Held After
62,374
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,163
Price
$22.19
Total Value
$25.81K
Shares Held After
62,474
% of Holdings
1.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
700
Price
$22.07
Total Value
$15.45K
Shares Held After
63,637
% of Holdings
1.1%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
64,337
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
443
Price
$21.78
Total Value
$9.65K
Shares Held After
64,537
% of Holdings
0.7%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
300
Price
$20.84
Total Value
$6.25K
Shares Held After
64,980
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,040
Price
$22.05
Total Value
$22.93K
Shares Held After
65,280
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,180
Price
$21.84
Total Value
$25.77K
Shares Held After
66,320
% of Holdings
1.7%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
400
Price
$22.02
Total Value
$8.81K
Shares Held After
67,500
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
6,970
Price
$22.03
Total Value
$153.55K
Shares Held After
67,900
% of Holdings
9.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
672
Price
$22.02
Total Value
$14.80K
Shares Held After
74,870
% of Holdings
0.9%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
753
Price
$21.97
Total Value
$16.54K
Shares Held After
75,542
% of Holdings
1.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
100
Price
$22.11
Total Value
$2.21K
Shares Held After
76,295
% of Holdings
0.1%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
480
Price
$21.55
Total Value
$10.34K
Shares Held After
76,395
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.10
Total Value
$4.42K
Shares Held After
76,875
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
3,402
Price
$22.02
Total Value
$74.91K
Shares Held After
77,075
% of Holdings
4.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,556
Price
$22.06
Total Value
$34.33K
Shares Held After
80,477
% of Holdings
1.9%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
76,418
Price
$21.04
Total Value
$1.61M
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
82,033
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
6,763
Price
$21.61
Total Value
$146.15K
Shares Held After
55,611
% of Holdings
10.8%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
100
Price
$21.99
Total Value
$2.20K
Shares Held After
62,374
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,332
Price
$22.03
Total Value
$29.34K
Shares Held After
82,233
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,163
Price
$22.19
Total Value
$25.81K
Shares Held After
62,474
% of Holdings
1.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
447
Price
$21.87
Total Value
$9.78K
Shares Held After
83,565
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
700
Price
$22.07
Total Value
$15.45K
Shares Held After
63,637
% of Holdings
1.1%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
64,337
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
988
Price
$22.03
Total Value
$21.77K
Shares Held After
84,012
% of Holdings
1.2%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
443
Price
$21.78
Total Value
$9.65K
Shares Held After
64,537
% of Holdings
0.7%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
300
Price
$20.84
Total Value
$6.25K
Shares Held After
64,980
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,040
Price
$22.05
Total Value
$22.93K
Shares Held After
65,280
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
85,000
Price
$21.00
Total Value
$1.78M
Shares Held After
85,000
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,180
Price
$21.84
Total Value
$25.77K
Shares Held After
66,320
% of Holdings
1.7%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
400
Price
$22.02
Total Value
$8.81K
Shares Held After
67,500
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
6,970
Price
$22.03
Total Value
$153.55K
Shares Held After
67,900
% of Holdings
9.3%
27626 transactions